KINGDON CAPITAL MANAGEMENT, L.L.C. - Q4 2022 holdings

$502 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 50 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .

 Value Shares↓ Weighting
BWXT  BWX TECHNOLOGIES INC$19,514,880
+15.3%
336,0000.0%3.89%
+79.5%
APG  API GROUP CORP$17,859,756
+41.7%
949,4820.0%3.56%
+120.6%
CARA  CARA THERAPEUTICS INC$14,316,420
+14.7%
1,333,0000.0%2.85%
+78.6%
WSC  WILLSCOT MOBIL MINI HLDNG CO$13,551,000
+12.0%
300,0000.0%2.70%
+74.3%
XAIR  BEYOND AIR INC$5,166,274
-12.8%
796,0360.0%1.03%
+35.8%
SLGL  SOL GEL TECHNOLOGIES$3,797,485
-9.2%
832,8000.0%0.76%
+41.3%
MSAC  MEDICUS SCIENCES ACQUISITION$3,021,000
+1.7%
300,0000.0%0.60%
+58.4%
GEG  GREAT ELM GROUP INC$2,785,679
+1.0%
1,379,0490.0%0.56%
+57.2%
SCYX  SCYNEXIS INC$2,023,395
-35.0%
1,297,0480.0%0.40%
+1.3%
OSTK  OVERSTOCK COM INC DEL$1,936,000
-20.5%
100,0000.0%0.38%
+23.8%
CRIS  CURIS INC$1,388,433
-21.4%
2,524,4240.0%0.28%
+22.1%
 ENVVENO MEDICAL CORPORATION$1,117,818
-18.8%
219,1800.0%0.22%
+26.7%
VINC  VINCERX PHARMA INC$392,700
-26.0%
385,0000.0%0.08%
+14.7%
 JASPER THERAPEUTICS INC$260,766
-38.8%
540,0000.0%0.05%
-3.7%
MSACW  MEDICUS SCIENCES ACQUISITION*w exp 02/12/202$3,117
+211.7%
33,3320.0%0.00%
EUCRW  EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202$3,540
+77.0%
66,6650.0%0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings